Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News BioDelivery Sciences International Inc. BDSI

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.


Recent & Breaking News (NDAQ:BDSI)

Endo Pharmaceuticals and BioDelivery Sciences Present New Data on Investigational Product Buprenorphine HCl Buccal Film for Chronic Pain Management

Canada NewsWire September 9, 2015

BioDelivery Sciences Secures Exclusive Preferred Formulary Status for BUNAVAIL® with Tennessee Medicaid (TennCare)

PR Newswire September 8, 2015

BioDelivery Sciences to Participate at the Wells Fargo Securities 2015 Healthcare Conference and the FBR Second Annual Healthcare Conference

PR Newswire September 3, 2015

BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS® (fentanyl buccal soluble film) CII

PR Newswire August 13, 2015

BioDelivery Sciences Strengthens Sales Force Leadership with Hiring of Scott Plesha, Former Salix Head of Sales

PR Newswire August 12, 2015

BioDelivery Sciences Provides Corporate Update and Reports Second Quarter 2015 Financial Results

PR Newswire August 10, 2015

BioDelivery Sciences to Host Conference Call and Webcast of Second Quarter 2015 Results on Monday, August 10

PR Newswire August 3, 2015

BioDelivery Sciences Announces Hiring of Enoch Bortey, Ph.D., as Vice President of Clinical Biostatistics and Data Systems

PR Newswire July 14, 2015

BioDelivery Sciences Announces Hiring of Stephana E. Patton as General Counsel

PR Newswire June 8, 2015

BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change

PR Newswire June 2, 2015

BioDelivery Sciences Adds $20 Million in Debt Financing from MidCap Financial

PR Newswire June 1, 2015

BioDelivery Sciences Strengthens BUNAVAIL Sales and Managed Markets Teams

PR Newswire May 28, 2015

BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference

PR Newswire May 27, 2015

Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain

Canada NewsWire May 14, 2015

BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2015 Financial Results

PR Newswire May 11, 2015

BioDelivery Sciences to Host Conference Call and Webcast of First Quarter 2015 Results on Monday, May 11

PR Newswire May 4, 2015

BioDelivery Sciences to Present at the Deutsche Bank 40th Annual Health Care Conference and the Bank of America Merrill Lynch 2015 Health Care Conference

PR Newswire April 30, 2015

BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs

PR Newswire April 28, 2015

BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development

PR Newswire March 30, 2015

BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results

PR Newswire March 16, 2015